Close

Barclays on U.S. Diagnostics: Policy, Macro Overhang Persists in Q3 Oct 17, 2011 02:50PM
Barclays Maintains an 'Overweight' on Illumina (ILMN); Moderating Expectations Due to Funding Uncertainty and New Product Dynamics Jul 27, 2011 01:05PM
Barclays on U.S. Diagnostics: Q2 Preview; 2H Volume Recovery Likely Slower Than Expected Jul 19, 2011 01:57PM
Barclays on U.S. Diagnostics: FDA Issues draft guidance on companion diagnostics; Positive read for QGEN Jul 13, 2011 01:11PM
Notable Analyst Rating Changes 07/06: (AXL) (TSO) (HEV) Upgraded; (NFLX) (INTU) (OC) Downgraded Jul 6, 2011 10:44AM


May 10, 2011 02:17PM Barclays Maintains an 'Overweight' on Qiagen NV (QGEN); EUROGIN Day 2: 'QIA'strategy restated
Apr 11, 2011 02:43PM Barclays on U.S. Diagnostics: Q1 2011 Preview
Apr 4, 2011 07:30AM Qiagen (QGEN) Announces $355M Acquisition of Cellestis Ltd.
Feb 23, 2011 10:49AM Notable Analyst Rating Changes 02/23: (AMAT) (AKS) (YOKU) (HOC) Upgraded; (NFLX) (FRX) (MDT) (MRO) Downgraded
Feb 2, 2011 01:32PM Barclays Maintains an 'Overweight' on Qiagen NV (QGEN); Weaker Q4 Unfolds Into Uninspiring FY'11
Dec 13, 2010 02:09PM Barclays Maintains an 'Overweight' Rating on Qiagen NV (QGEN); Management Meetings & Facility Tour
Oct 7, 2009 08:15AM Barclays Initiates Coverage on Qiagen (QGEN) with an Overweight
Jul 10, 2009 09:55AM Notable Analyst Rating Changes 7/10: DELL, WFR, DRYS, DAN, NYX Upgraded; IBM, QGEN, TSON, FC Downgraded